Ani Pharmaceuticals
(NASDAQ) ANIP
Ani Pharmaceuticals Financials at a Glance
Market Cap
$1.84B
Revenue (TTM)
$923.71M
Net Income (TTM)
$89.67M
EPS (TTM)
$3.94
P/E Ratio
20.58
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Price
$78.49
Volume
429,965.248
Open
$80.73
Price
$78.49
Volume
429,965.248
Open
$80.73
Previous Close
$78.51
Daily Range
$78.13 - $81.30
52-Week Range
$57.45 - $99.50
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Price
$78.49
Volume
429,965.248
Open
$80.73
Previous Close
$78.51
Daily Range
$78.13 - $81.30
52-Week Range
$57.45 - $99.50
ANIP News
ANIP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ani Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
970
CEO
Nikhil Lalwani, MBA
Website
www.anipharmaceuticals.comHeadquarters
Baudette, MN 56623, US
ANIP Financials
Key Financial Metrics (TTM)
Gross Margin
66%
Operating Margin
13%
Net Income Margin
10%
Return on Equity
17%
Return on Capital
10%
Return on Assets
6%
Earnings Yield
4.86%
Dividend Yield
0.00%
Payout Ratio
0.84%
Stock Overview
Market Cap
$1.84B
Shares Outstanding
22.75M
Volume
429.97K
Avg. Volume
372.74K
Financials (TTM)
Gross Profit
$450.64M
Operating Income
$81.23M
EBITDA
$207.27M
Operating Cash Flow
$185.23M
Capital Expenditure
-$13.84M
Free Cash Flow
$171.39M
Cash & ST Invst.
$285.59M
Total Debt
$325.20M
Ani Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$237.46M
+20.5%
Gross Profit
$122.96M
-0.9%
Gross Margin
51.78%
N/A
Market Cap
$1.84B
N/A
Market Cap/Employee
$2.06M
N/A
Employees
897
N/A
Net Income
$29.49M
+88.1%
EBITDA
$59.63M
+23.3%
Quarterly Fundamentals
Net Cash
-$16.59M
+96.5%
Accounts Receivable
$255.43M
+15.9%
Inventory
$143.47M
+4.4%
Long Term Debt
$308.47M
-49.6%
Short Term Debt
$19.30M
+72.4%
Return on Assets
6.31%
N/A
Return on Invested Capital
10.45%
N/A
Free Cash Flow
$52.30M
+245.3%
Operating Cash Flow
$58.38M
+66.8%